Clinical Outcome between Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndrome and Diabetes

Clinical Outcome between Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndrome and Diabetes

Background. The increased thrombotic risk in patients with acute coronary syndrome (ACS) and diabetes highlights the need for adequate antithrombotic protection. We aimed to compare the 6-month clinical outcomes between ticagrelor and clopidogrel in patients with ACS and diabetes. Methods and Result...

Full description

Saved in:

Bibliographic Details
Main Authors:	Peixun He, Xiaolin Luo, Jiabei Li, Yi Li, Xiaozeng Wang, Lan Huang, Jun Jin, Yaling Han
Format:	Article
Language:	English
Published:	Wiley 2021-01-01
Series:	Cardiovascular Therapeutics
Online Access:	http://dx.doi.org/10.1155/2021/5546260
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Comparison of Ticagrelor and Clopidogrel in Elective Coronary Stenting: A Double Blind Randomized Clinical Trial
by: Mohammadjavad Mehdizadeh Parizi, et al.
Published: (2023-01-01)

Stent Thrombosis Patients with Hyporesponsiveness to Clopidogrel, Prasugrel, and Ticagrelor: A Case Series Using Short Thromboelastography
by: Bartosz Olechowski, et al.
Published: (2016-01-01)

The Effect of Clopidogrel and Ticagrelor on Human Adipose Mesenchymal Stem Cell Osteogenic Differentiation Potential: In Vitro Comparative Study
by: Sally S. Mohamed, et al.
Published: (2024-01-01)

Effect of ticagrelor combined with metoprolol extended-release tablets on cardiac function and clinical prognosis in elderly patients with acute coronary syndrome after percutaneous coronary intervention
by: Lili Wang, et al.
Published: (2025-01-01)

Lower Plasma miR-223 Level Is Associated with Clopidogrel Resistance in Acute Coronary Syndrome: A Systematic Review and Meta-Analysis
by: Hang Cheng, et al.
Published: (2023-01-01)

Both CYP2C19 and PON1 Q192R Genotypes Influence Platelet Response to Clopidogrel by Thrombelastography in Patients with Acute Coronary Syndrome
by: Wenxing Peng, et al.
Published: (2019-01-01)

Clopidogrel-Induced Neutropenia after Coronary Stenting: Is Cilostazol a Good Alternative?
by: Massimo Montalto, et al.
Published: (2011-01-01)

A Case of Atrioventricular Block Potentially Associated with Right Coronary Artery Lesion and Ticagrelor Therapy Mediated by the Increasing Adenosine Plasma Concentration
by: Xiaoye Li, et al.
Published: (2018-01-01)

Ticagrelor-Induced Angioedema: A Rare and Unexpected Phenomenon
by: Rajeev Seecheran, et al.
Published: (2017-01-01)

Ticagrelor Associated Heart Block: The Need for Close and Continued Monitoring
by: Munish Sharma, et al.
Published: (2017-01-01)

Residual Dyslipidemia Leads to Unfavorable Outcomes in Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention
by: Bin Que, et al.
Published: (2016-01-01)

Acute Coronary Syndrome Mimicking Takotsubo Cardiomyopathy or Takotsubo Cardiomyopathy Mimicking Acute Coronary Syndrome?
by: Martin Chaumont, et al.
Published: (2020-01-01)

Relationship between CYP2C19 Polymorphism and Clopidogrel Resistance in Patients with Coronary Heart Disease and Ischemic Stroke in China
by: Rong Chang, et al.
Published: (2022-01-01)

Polyvascular Disease in Patients Presenting with Acute Coronary Syndrome: Its Predictors and Outcomes
by: Hassan Al Thani, et al.
Published: (2012-01-01)

The Role of Clopidogrel in 2020: A Reappraisal
by: Giuseppe Patti, et al.
Published: (2020-01-01)

Association between Peak Neutrophil Count, Clopidogrel Loading Dose, and Left Ventricular Systolic Function in Patients with Primary Percutaneous Coronary Intervention
by: Xinyu Wang, et al.
Published: (2014-01-01)

Association of Time in Target Range of Resting Heart Rate With Adverse Clinical Outcomes in Patients With Acute Coronary Syndromes After Percutaneous Coronary Intervention
by: Jianmei Zheng, et al.
Published: (2025-01-01)

Th22 Cell Is a Gradually Proved Potential Biomarker for Acute Coronary Syndrome
by: Ying Huang, et al.
Published: (2014-01-01)

Association of β-Blocker Therapy at Discharge with Clinical Outcomes after Acute Coronary Syndrome in Patients without Heart Failure
by: Yan Chen, et al.
Published: (2020-01-01)

Heparin and Bivalirudin in Percutaneous Coronary Intervention for Acute Coronary Syndromes: A Review Article
by: Guiping Wang, et al.
Published: (2024-01-01)

Approach to acute chest pain and acute coronary syndrome in adults
by: Isaac Kah Siang Ng, et al.
Published: (2024-02-01)

Acute Coronary Syndrome: An Unusual Consequence of GERD
by: Chui Man Carmen Hui, et al.
Published: (2015-01-01)

Migratory Polyarthritis Associated With Clopidogrel: A Case Report
by: Hamid Khederlou, et al.
Published: (2024-12-01)

The Relationship of Conduction Disorder and Prognosis in Patients with Acute Coronary Syndrome
by: Wei-Chieh Lee, et al.
Published: (2022-01-01)

Optical Coherence Tomography Imaging in Acute Coronary Syndromes
by: Takashi Kubo, et al.
Published: (2011-01-01)

Prediction Model of New Onset Atrial Fibrillation in Patients with Acute Coronary Syndrome
by: Na Wu, et al.
Published: (2023-01-01)

The impact of uric acid on acute coronary syndrome prognosis in elderly patients
by: Yifan Li, et al.
Published: (2025-12-01)

The Personalization of Clopidogrel Antiplatelet Therapy: The Role of Integrative Pharmacogenetics and Pharmacometabolomics
by: Arwa M. Amin, et al.
Published: (2017-01-01)

Long-Term Clinical Outcomes for Non-ST Elevation Acute Coronary Syndrome Patients with High-Risk Angiographic Findings Undergoing Percutaneous Coronary Intervention
by: Sida Jia, et al.
Published: (2020-01-01)

Comparative bioavailability of two oral formulations of clopidogrel: Determination of clopidogrel and its carboxylic acid metabolite (SR26334) under fasting and fed conditions in healthy subjects
by: Brvar Nina, et al.
Published: (2014-03-01)

Acute Coronary Syndrome in Acute Myeloid Leukemia with Maturation Accompanying Megakaryocytic Differentiation
by: Kentaro Odani, et al.
Published: (2020-01-01)

Assessment of Clinical Features in HIV-Infected Patients with Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention in China
by: Ying Liu, et al.
Published: (2022-01-01)

The Rise of Transradial Artery Access for Percutaneous Coronary Intervention in Patients with Acute Coronary Syndromes in Australia
by: Ryan James Ocsan, et al.
Published: (2020-01-01)

Acute Coronary Syndrome (ACS) due to Coronary Artery Embolism in a Patient with Atrial Fibrillation
by: Hussein Daoud, et al.
Published: (2019-01-01)

Both Low and High Postprocedural hsCRP Associate with Increased Risk of Death in Acute Coronary Syndrome Patients Treated by Percutaneous Coronary Intervention
by: Runzhen Chen, et al.
Published: (2020-01-01)

Pocket Reference to The 12-Lead ECG in Acute Coronary Syndromes /
by: Phalen, Tim
Published: (2012)

Receptor Inhibitors in Acute Coronary Syndromes: What Is New on the Horizon?
by: Adriana Dana Oprea, et al.
Published: (2013-01-01)

Comorbidity and risk of cardiac events in patients with acute coronary syndrome
by: R.R. Komorovsky
Published: (2019-03-01)

Comparison of effectiveness of aspirin, clopidogrel and cilostazol monotherapy treatment in ischaemic stroke
by: Endarwati Tuti, et al.
Published: (2025-01-01)

Plasma Granzyme B in ST Elevation Myocardial Infarction versus Non-ST Elevation Acute Coronary Syndrome: Comparisons with IL-18 and Fractalkine
by: Hala O. El-Mesallamy, et al.
Published: (2013-01-01)